Outlook Therapeutics Appoints Laura Cantrell as Vice President of Corporate Strategy and Business Development
(NASDAQ:OTLK),(NASDAQ:OTLKW), ISELIN, N.J., Jan. 06, 2026 (GLOBE NEWSWIRE) — Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company focused on enhancing the standard of care for bevacizumab for the treatment of retina diseases, today announced it has appointed Laura Cantrell as Vice President of Corporate Strategy and Business Development. “We are very pleased to welcome Laura […]